Fagron N.V.
A global pharmaceutical compounding company focused on personalized medicine.
FAGR | BR
Overview
Corporate Details
- ISIN(s):
- BE0003874915
- LEI:
- 549300TRKRUFK2RRG779
- Country:
- Belgium
- Address:
- Venecoweg 20A, 9810 Nazareth
- Website:
- https://fagron.com/
- Sector:
- Manufacturing
Description
Fagron N.V. is a global company active in pharmaceutical compounding, focusing on the delivery of personalized medicine. The company optimizes and innovates compounding to widen the therapeutic options for prescribers worldwide. Fagron develops, markets, and distributes pharmaceutical raw materials, equipment, and specially formulated vehicles and bases, such as the Pentravan® transdermal base and the SyrSpend® range of oral suspending vehicles. Its primary customers are hospitals, pharmacies, and clinics. The company also operates in the field of genomics to further support personalized healthcare solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2016-08-05 07:00 |
DEF ENG 050816.pdf
|
Dutch | 550.4 KB | ||
| 2016-08-05 07:00 |
Interim financial statements first semester of 2016.pdf
|
English | 2.8 MB | ||
| 2016-08-05 07:00 |
Tussentijdse financiele informatie eerste semester 2016.pdf
|
Dutch | 3.0 MB | ||
| 2016-07-29 19:30 |
DEF ENG 290716.pdf
|
English | 85.5 KB | ||
| 2016-07-29 19:30 |
DEF NED 290716.pdf
|
Dutch | 89.3 KB | ||
| 2016-07-22 08:09 |
Fagron receives claim with regard to acquisition of AnazaoHealth
|
English | 71.9 KB | ||
| 2016-07-22 08:09 |
Fagron receives claim with regard to acquisition of AnazaoHealth
|
English | 73.1 KB | ||
| 2016-07-22 07:00 |
Fagron receives claim with regard to acquisition of AnazaoHealth
|
English | 71.9 KB | ||
| 2016-07-22 07:00 |
Fagron ontvangt claim met betrekking tot de overname van AnazaoHealth
|
Dutch | 73.1 KB | ||
| 2016-07-18 08:36 |
Fagron NV: Disclosure of received notification
|
Dutch | 115.5 KB | ||
| 2016-07-18 08:36 |
Fagron NV: Disclosure of received notification
|
Dutch | 112.5 KB | ||
| 2016-07-15 19:35 |
A32212436 v0.2 Red_Transparantiekennisgeving_7juli2016_signed.pdf
|
Dutch | 162.7 KB | ||
| 2016-07-15 19:35 |
A31939223 v1.0 Red_Transparancy Notification_Structure Chart.pdf
|
Dutch | 36.7 KB | ||
| 2016-07-15 19:35 |
DEF ENG 150716 Kennisgeving.pdf
|
English | 126.3 KB | ||
| 2016-07-15 19:35 |
DEF NED 150716 Kennisgeving.pdf
|
Dutch | 129.1 KB |
Automate Your Workflow. Get a real-time feed of all Fagron N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Fagron N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Fagron N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-23 | Pulido Andrew | Executive member | Sell | 85,000 | 1,803,351.50 EUR |
| 2025-05-22 | Pulido Andrew | Executive member | Buy | 85,000 | 1,617,550.00 EUR |
| 2025-05-02 | De Jong Cornelia Neeltje | Board | Sell | 12,689 | 263,834.55 EUR |
| 2025-04-30 | De Jong Cornelia Neeltje | Board | Sell | 229 | 4,660.15 EUR |
| 2025-04-29 | De Jong Cornelia Neeltje | Board | Sell | 10,000 | 201,500.00 EUR |
| 2025-03-28 | J. Verlinden | Other | Buy | 24,551 | 453,702.48 EUR |
| 2025-03-28 | J. Verlinden | Other | Sell | 17,930 | 344,047.56 EUR |
| 2025-03-27 | Padilla Rafael | Board | Buy | 78,469 | 1,450,107.12 EUR |
| 2025-03-27 | De Jong Cornelia Neeltje | Board | Buy | 45,418 | 839,324.64 EUR |
| 2025-02-21 | Bakker Vera | Executive member | Buy | 773 | 15,000.00 EUR |
Peer Companies
